Status:

COMPLETED

A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia

Lead Sponsor:

Astellas Pharma Inc

Conditions:

Dyspepsia

Functional Dyspepsia

Eligibility:

All Genders

20-79 years

Phase:

PHASE3

Brief Summary

To examine the safety and efficacy of Z-338 (YM443) after long-term administration in patients with functional dyspepsia, and also to examine the pattern of long-term administration.

Eligibility Criteria

Inclusion

  • Patient showing at least one of the following 4 symptoms from more than 6 months before obtaining consent
  • postprandial fullness
  • early satiation
  • upper abdominal pain
  • upper abdominal discomfort
  • Patient showing at least 2 of the 8 symptoms shown below repeatedly from 3 months before obtaining consent (At least one symptom of either postprandial fullness or early satiation should be included.)
  • Patient showing either postprandial fullness, bloating in the upper abdomen, or early satiation as the major complaint among the 8 symptoms shown below at the time of obtaining consent
  • upper abdominal pain
  • upper abdominal discomfort
  • postprandial fullness
  • bloating in the upper abdomen
  • early satiation
  • nausea
  • vomiting
  • belching
  • Outpatient

Exclusion

  • Patient showing symptoms of organic disease (reflux esophagitis, erosion, ulceration, esophageal hiatal hernia, bleeding, malignant tumor, Barrett's esophagus) when upper gastrointestinal endoscopy is performed within 24 weeks before obtaining consent
  • Patient showing heartburn within 12 weeks before obtaining consent
  • Patient complicated by irritable bowel syndrome
  • Patient complicated by diabetes mellitus requiring medication
  • Patient complicated by severe anxiety disorder with some problems in interpersonal relationships or social life
  • Patient complicated by depression (including suspected cases) or sleep disturbance

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

412 Patients enrolled

Trial Details

Trial ID

NCT00764374

Start Date

August 1 2008

End Date

December 1 2009

Last Update

October 29 2014

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hokkaido, Japan

2

Kansai, Japan

3

Kantou, Japan

4

Kyushu, Japan